• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒肺炎重症监护病房患者的血栓栓塞和出血事件:来自巴西一家三级医院的结果

Thromboembolic and bleeding events in intensive care unit patients with COVID-19: results from a Brazilian tertiary hospital.

作者信息

Brandão Antonio Adolfo Guerra Soares, de Oliveira Cleyton Zanardo, Rojas Salomon Ordinola, Ordinola Amanda Ayako Minemura, Queiroz Victoria Masi, de Farias Danielle Leão Cordeiro, Scheinberg Phillip, Veiga Viviane Cordeiro

机构信息

BP- A Beneficência Portuguesa de São Paulo, São Paulo, Brazil; Instituto do Câncer do Estado de São Paulo, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.

BP- A Beneficência Portuguesa de São Paulo, São Paulo, Brazil.

出版信息

Int J Infect Dis. 2021 Dec;113:236-242. doi: 10.1016/j.ijid.2021.10.020. Epub 2021 Oct 17.

DOI:10.1016/j.ijid.2021.10.020
PMID:34670141
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8520502/
Abstract

OBJECTIVES

To describe the incidence of thromboembolic events in adult patients with severe COVID-19 and identify clinical and laboratory factors associated with these events.

DESIGN

Observational retrospective cohort study of 243 adult patients with severe COVID-19 admitted to an intensive care unit (ICU) at a Brazilian tertiary hospital.

RESULTS

The incidence of all thromboembolic events was 14.8%, in which 3.8% developed deep vein thrombosis, 7.8% pulmonary embolism, 2.5% acute myocardial infarction, 1.2% stroke, and 1.2% peripheral artery occlusion. Risk factors identified were D-dimer at admission >3000 ng/mL (P=<0.0013) and major bleeding (P=0.001). The cumulative risk of developing thromboembolic events at day 28 after ICU admission was 16.0%. The rate of major bleeding was 4.1%. After receiver operating characteristic curve analysis, the D-dimer cut-off at admission correlating with thromboembolic events was 1140.5 ng/mL.

CONCLUSIONS

The rate of thromboembolic events in our study was lower than previously described. High D-dimer level at admission was the leading risk factor; the optimal cut-off was 1140.5 ng/mL. The occurrence of thromboembolic events did not have an impact on the median overall survival rate. The optimal anticoagulant strategy in this context still needs to be established.

摘要

目的

描述重症新型冠状病毒肺炎(COVID-19)成年患者血栓栓塞事件的发生率,并确定与这些事件相关的临床和实验室因素。

设计

对巴西一家三级医院重症监护病房(ICU)收治的243例重症COVID-19成年患者进行观察性回顾性队列研究。

结果

所有血栓栓塞事件的发生率为14.8%,其中3.8%发生深静脉血栓形成,7.8%发生肺栓塞,2.5%发生急性心肌梗死,1.2%发生中风,1.2%发生外周动脉闭塞。确定的危险因素为入院时D-二聚体>3000 ng/mL(P<0.0013)和大出血(P=0.001)。ICU入院后第28天发生血栓栓塞事件的累积风险为16.0%。大出血发生率为4.1%。经过受试者工作特征曲线分析,与血栓栓塞事件相关的入院时D-二聚体临界值为1140.5 ng/mL。

结论

我们研究中的血栓栓塞事件发生率低于先前描述的发生率。入院时D-二聚体水平高是主要危险因素;最佳临界值为1140.5 ng/mL。血栓栓塞事件的发生对总体中位生存率没有影响。在这种情况下,最佳抗凝策略仍有待确定。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a780/8520502/bd60bc4071ec/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a780/8520502/8021824332e8/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a780/8520502/bff38e30bbc7/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a780/8520502/3f1f1fa83d4e/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a780/8520502/bd60bc4071ec/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a780/8520502/8021824332e8/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a780/8520502/bff38e30bbc7/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a780/8520502/3f1f1fa83d4e/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a780/8520502/bd60bc4071ec/gr4_lrg.jpg

相似文献

1
Thromboembolic and bleeding events in intensive care unit patients with COVID-19: results from a Brazilian tertiary hospital.新型冠状病毒肺炎重症监护病房患者的血栓栓塞和出血事件:来自巴西一家三级医院的结果
Int J Infect Dis. 2021 Dec;113:236-242. doi: 10.1016/j.ijid.2021.10.020. Epub 2021 Oct 17.
2
Thromboembolic and bleeding events in ICU patients with COVID-19: A nationwide, observational study.COVID-19 重症监护病房患者的血栓栓塞和出血事件:一项全国性观察研究。
Acta Anaesthesiol Scand. 2023 Jan;67(1):76-85. doi: 10.1111/aas.14157. Epub 2022 Nov 6.
3
Thromboembolic Events and Role of Point of Care Ultrasound in Hospitalized Covid-19 Patients Needing Intensive Care Unit Admission.住院的需要入住重症监护病房的新冠病毒患者中的血栓栓塞事件和即时护理超声的作用。
J Intensive Care Med. 2021 Dec;36(12):1483-1490. doi: 10.1177/0885066620964392. Epub 2020 Oct 6.
4
Deep vein thrombosis in hospitalized patients with coronavirus disease 2019.COVID-19 住院患者的深静脉血栓形成。
J Vasc Surg Venous Lymphat Disord. 2021 May;9(3):597-604. doi: 10.1016/j.jvsv.2020.09.010. Epub 2020 Oct 8.
5
Thromboembolic Rates Are Similar Between Intensive Care Unit and Nonintensive Care Unit Hospitalized Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Retrospective Cohort Study.重症监护病房与非重症监护病房的新型冠状病毒 2 型(SARS-CoV-2)感染重症患者的血栓栓塞发生率相似:一项回顾性队列研究
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211053315. doi: 10.1177/10760296211053315.
6
Fibrinolysis Shutdown Correlation with Thromboembolic Events in Severe COVID-19 Infection.严重 COVID-19 感染中纤维蛋白溶解关闭与血栓栓塞事件的相关性。
J Am Coll Surg. 2020 Aug;231(2):193-203.e1. doi: 10.1016/j.jamcollsurg.2020.05.007. Epub 2020 May 15.
7
Incidence of deep venous thrombosis in COVID-19 hospitalized patients during the first peak of the Italian outbreak.意大利疫情首次高峰期间住院 COVID-19 患者深静脉血栓形成的发生率。
Phlebology. 2021 Jun;36(5):375-383. doi: 10.1177/0268355520975592. Epub 2020 Nov 26.
8
[Thromboembolic complications in patients with COVID-19].[新型冠状病毒肺炎患者的血栓栓塞并发症]
Medicina (B Aires). 2022;82(1):21-27.
9
Assessing the Impact of Inflammatory Markers and CT Severity Score on Disease Severity of COVID-19 Patients Admitted to ICU at a Tertiary Hospital.评估炎症标志物和 CT 严重程度评分对入住三级医院 ICU 的 COVID-19 患者疾病严重程度的影响。
J Assoc Physicians India. 2021 Jun;69(6):11-12.
10
Prevalence of Elevated D-dimer Levels in Confirmed COVID-19 Cases in Intensive Care Unit of a Tertiary Care Centre of Western Nepal.尼泊尔西部一家三级护理中心重症监护病房中确诊 COVID-19 病例中 D-二聚体水平升高的流行情况。
JNMA J Nepal Med Assoc. 2021 Mar 31;59(235):243-247. doi: 10.31729/jnma.6284.

引用本文的文献

1
A systematic review of thromboembolic complications and outcomes in hospitalised COVID-19 patients.一项关于住院 COVID-19 患者血栓栓塞并发症和结局的系统回顾。
BMC Infect Dis. 2024 May 10;24(1):484. doi: 10.1186/s12879-024-09374-1.
2
Thrombosis questions from the inpatient wards.住院病房的血栓相关问题。
Hematology Am Soc Hematol Educ Program. 2022 Dec 9;2022(1):481-490. doi: 10.1182/hematology.2022000384.